Repligen Corporation to Showcase Innovations at Major Conference
WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN), a leader in bioprocessing technologies, is excited to announce its participation in the highly anticipated 43rd Annual J.P. Morgan Healthcare Conference. Scheduled to take place in San Francisco, the conference is an influential gathering for industry professionals, happening January 13-16. Repligen's President and CEO, Olivier Loeillot, will present vital insights about the company on Tuesday, January 14 at 1:30 p.m. PT.
Live Webcast and Replay Information
For those unable to attend in person, Repligen will offer a live webcast of its presentation. Interested individuals can access the webcast via the company’s Investor Relations website and will have the opportunity to view a replay of the presentation for a limited time following the event.
Overview of Repligen Corporation
Repligen Corporation is committed to providing cutting-edge bioprocessing technologies designed to optimize the production of biological drugs. With a mission to “inspire advances in bioprocessing,” Repligen primarily serves biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) on a global scale. The company focuses on key areas such as Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins.
Global Presence and Manufacturing Expertise
The company operates from its corporate headquarters located in Waltham, Massachusetts, and boasts numerous manufacturing sites across the United States. Additionally, Repligen has key operations in Estonia, France, Germany, Ireland, the Netherlands, and Sweden, enhancing its ability to serve customers effectively worldwide.
Technological Advancements
Repligen's commitment to innovation is evident in its range of products that streamline and improve the manufacturing processes of biological medical products. The company’s continuous research and development efforts ensure that they remain at the forefront of bioprocessing technology, adapting to the ever-evolving healthcare landscape.
Engagement Through LinkedIn
For updates and more information, follow Repligen on LinkedIn. This platform allows the company to connect with stakeholders and share insights about their journey, innovations, and participation in significant events like the J.P. Morgan Healthcare Conference.
Frequently Asked Questions
What is the J.P. Morgan Healthcare Conference?
The J.P. Morgan Healthcare Conference is one of the largest healthcare investment symposiums, attracting key industry players and investors.
When will Repligen Corporation's presentation take place?
Olivier Loeillot, Repligen's President and CEO, will present on January 14 at 1:30 p.m. PT.
How can I watch Repligen's presentation?
A live webcast will be available on Repligen's Investor Relations website, with a replay accessible afterward.
What areas does Repligen specialize in?
Repligen specializes in Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins.
How can I contact Repligen Corporation?
You can reach out to Sondra S. Newman, VP, Global Head of Investor Relations, at (781) 419-1881 or via email at investors@repligen.com.
